Search - tctmd.com

Displaying 221 - 240 of 881

Sort: Relevancy | Date

News Daily News

Does the Watchman LAA Occluder Reduce Bleeding?

L.A. McKeown

November 25, 2015

News Daily News

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

Yael L. Maxwell

November 24, 2015

News Daily News

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Caitlin E. Cox

November 23, 2015

News Industry News

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

November 19, 2015

News Conference News AHA 2015

Is Watchman Cost-effective? That Depends Where You Look

Todd Neale

November 07, 2015

News Daily News

NEJM Endorses Robert Califf for FDA Commissioner

L.A. McKeown

October 30, 2015

News Daily News

Younger Women With STEMI More Likely Than Men to Die In-Hospital

L.A. McKeown

October 28, 2015

News Daily News

First NOAC Antidote, Idarucizumab, Approved; Likely Won’t Hold Up Interventions

Todd Neale

October 26, 2015

News Industry News

Carnegie Mellon Researchers Hack Off-the-Shelf 3-D Printer Towards Rebuilding the Heart

October 26, 2015

News Industry News

Medtronic Receives CE Mark for New Single-Chamber ICDs That Can Detect Atrial Fibrillation

October 21, 2015

News Industry News

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

October 20, 2015

Presentation TCT 2015

Incidence, Significance, and Management of New-Onset Atrial Fibrillation After TAVR

Presenter: Isaac George, Augusto D. Pichard, Alec S. Vahanian

October 15, 2015

Presentation TCT 2015

Miscellaneous Emerging Technologies 4: Stent-Based Pulmonary Vein Isolation Approach to Atrial Fibrillation

Presenter: Greg L. Kaluza, Joachim Schofer, Glenn Van Langenhove

October 15, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

Presentation TCT 2015

Putting It All Together: How to Manage the Patient With Atrial Fibrillation Undergoing PCI

Presenter: Gerhard C. Schuler, Matthew J. Price

October 14, 2015

Presentation TCT 2015

Considerations Regarding Renal Function in the Patient With Atrial Fibrillation

Presenter: Gerhard C. Schuler, C. Michael Gibson

October 14, 2015

Presentation TCT 2015

Device-Detected, Subclinical Atrial Fibrillation: Now What?

Presenter: Gerhard C. Schuler, Freek W.A. Verheugt

October 14, 2015

Presentation TCT 2015

Alternatives to Anticoagulation: Left Atrial Appendage Occlusion Devices

Presenter: Gerhard C. Schuler, Matthew J. Price

October 14, 2015

Presentation TCT 2015

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Presenter: Pascal Vranckx, Roxana Mehran

October 14, 2015

Advertisement

Does the Watchman LAA Occluder Reduce Bleeding?

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

Is Watchman Cost-effective? That Depends Where You Look

NEJM Endorses Robert Califf for FDA Commissioner

Younger Women With STEMI More Likely Than Men to Die In-Hospital

First NOAC Antidote, Idarucizumab, Approved; Likely Won’t Hold Up Interventions

Carnegie Mellon Researchers Hack Off-the-Shelf 3-D Printer Towards Rebuilding the Heart

Medtronic Receives CE Mark for New Single-Chamber ICDs That Can Detect Atrial Fibrillation

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

Incidence, Significance, and Management of New-Onset Atrial Fibrillation After TAVR

Miscellaneous Emerging Technologies 4: Stent-Based Pulmonary Vein Isolation Approach to Atrial Fibrillation

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Putting It All Together: How to Manage the Patient With Atrial Fibrillation Undergoing PCI

Considerations Regarding Renal Function in the Patient With Atrial Fibrillation

Device-Detected, Subclinical Atrial Fibrillation: Now What?

Alternatives to Anticoagulation: Left Atrial Appendage Occlusion Devices

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content